Preventing Adverse Reactions in Novice Blood Donors

预防新手献血者的不良反应

基本信息

  • 批准号:
    7766224
  • 负责人:
  • 金额:
    $ 35.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

Severe and potentially dangerous shortages in the blood supply are common. This problem is expected to worsen as the population ages (increasing demand) and more and more stringent restrictions are placed on blood donor eligibility (decreasing supply). A crucial component of the effort to meet the increasing demand for blood is the ongoing recruitment of new donors. Ideally, new recruits would become lifelong donors, contributing up to six times per year and hundreds of units of blood in a lifetime. Unfortunately, less than half of all novice donors will ever provide a second donation. Because the experience of vasovagal reactions (e.g., dizziness, weakness, lightheadedness) is one of the strongest predictors of attrition in novice donors, prevention of such reactions may be a particularly efficient and enduring method of enhancing the nation's blood supply. Our long-term objective is to provide blood collection agencies with simple and inexpensive strategies that can be used to prevent vasovagal reactions and enhance donor retention. The specific aim of the current proposal is to evaluate the combined effects of two particularly promising vasovagal prevention strategies - water loading and applied muscle tension. We will compare vasovagal reactions to blood donation and repeat donation behavior in 400 first-time donors assigned to either active treatment (pre- donation water loading and muscle tensing during donation) or placebo treatment (pre-donation muscle tensing). Participants will be recruited and tested at American Red Cross fixed and mobile blood donation clinics held in rural and urban settings. Vasovagal reactions will be measured using on-site donor and phlebotomist ratings as well as donor ratings obtained 24 hours later. Using the American Red Cross national donor database, subsequent donation history will be tracked during a two-year follow-up period. We hypothesize that participants in the active treatment group will experience less adverse reactions and will be more likely to return to provide a new donation as compared to participants in the placebo group. The proposed study tests simple strategies that volunteer blood donors can use to prevent negative reactions, such as fainting, that frequently discourage donors from returning. The long term goal of our work is to address recurrent shortages in the blood supply by increasing donor motivation and commitment to lifelong giving. Because we are working directly with the American Red Cross, our findings can be quickly translated into practice.
严重和潜在危险的血液供应短缺是常见的。这一问题有望 随着人口老龄化(需求增加)和越来越严格的限制, 献血资格(减少供应)。努力满足日益增长的 对血液的需求是不断招募新的献血者。理想情况下,新招募的人员将成为终身 献血者,每年捐献多达六次,一生中捐献数百单位的血液。不幸的是, 超过一半的新手捐赠者会提供第二次捐赠。因为血管迷走神经 反应(例如,头晕、无力、头晕)是新手中最强的磨损预测因素之一 因此,预防这种反应可能是增强免疫反应的特别有效和持久的方法。 国家的血液供应。 我们的长期目标是为采血机构提供简单和廉价的策略 可用于预防血管迷走神经反应和增强供体保留。的具体目标 目前的建议是评估两种特别有希望的血管迷走神经预防的联合作用。 策略-水负荷和施加肌肉张力。我们将比较血管迷走神经反应和血液 400名首次献血者的献血和重复献血行为, 捐赠期间的捐赠水负荷和肌肉紧张)或安慰剂治疗(捐赠前肌肉 紧张)。参与者将在美国红十字会的固定和移动的献血中招募和测试 在农村和城市设立的诊所。将使用现场供体测量血管迷走神经反应, 24小时后获得抽血者评级以及供体评级。使用美国红十字会 国家捐赠者数据库,随后的捐赠历史将在两年的随访期内跟踪。我们 假设积极治疗组的参与者将经历较少的不良反应, 与安慰剂组的参与者相比,更有可能返回提供新的捐赠。 这项拟议中的研究测试了志愿献血者可以用来预防阴性反应的简单策略。 反应,如昏厥,这往往使捐助者不愿返回。我们工作的长期目标 是通过增加捐赠者的动机和承诺来解决血液供应的经常性短缺, 终身奉献因为我们直接与美国红十字会合作,我们的调查结果可以很快 转化为实践。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher R France其他文献

Neighborhood ethnic density and disparities in proximal blood donation opportunities
社区种族密度和近端献血机会的差异
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    John M Ruiz;Shana D. Hughes;Melissa Flores;Brian Custer;M. Ingram;Scott Carvajal;Cecilia Rosales;Hany T. Kamel;Ralph Vassallo;Christopher R France
  • 通讯作者:
    Christopher R France

Christopher R France的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher R France', 18)}}的其他基金

Virtual Immersive Gaming to Optimize Recovery in Low Back Pain
虚拟沉浸式游戏可优化腰痛恢复
  • 批准号:
    10058238
  • 财政年份:
    2018
  • 资助金额:
    $ 35.61万
  • 项目类别:
Virtual Immersive Gaming to Optimize Recovery in Low Back Pain
虚拟沉浸式游戏可优化腰痛恢复
  • 批准号:
    10558448
  • 财政年份:
    2018
  • 资助金额:
    $ 35.61万
  • 项目类别:
Blood Donor Competence, Autonomy and Relatedness Enhancement (Blood Donor CARE)
献血者能力、自主性和相关性增强(献血者护理)
  • 批准号:
    9204858
  • 财政年份:
    2016
  • 资助金额:
    $ 35.61万
  • 项目类别:
Blood Donor Competence, Autonomy and Relatedness Enhancement (Blood Donor CARE)
献血者能力、自主性和相关性增强(献血者护理)
  • 批准号:
    9012195
  • 财政年份:
    2016
  • 资助金额:
    $ 35.61万
  • 项目类别:
Development of a Virtual Reality Graded Exposure Intervention for Low Back Pain
开发针对腰痛的虚拟现实分级暴露干预措施
  • 批准号:
    9350270
  • 财政年份:
    2016
  • 资助金额:
    $ 35.61万
  • 项目类别:
Motivating Type O- Blood Donors to Return
激励 O 型献血者回归
  • 批准号:
    8903574
  • 财政年份:
    2014
  • 资助金额:
    $ 35.61万
  • 项目类别:
Using an interactive game to reduce fear & increase spine motion in low back pain
使用互动游戏减少恐惧
  • 批准号:
    8667104
  • 财政年份:
    2014
  • 资助金额:
    $ 35.61万
  • 项目类别:
Preventing Adverse Reactions in Novice Blood Donors
预防新手献血者的不良反应
  • 批准号:
    7576717
  • 财政年份:
    2006
  • 资助金额:
    $ 35.61万
  • 项目类别:
Preventing Adverse Reactions in Novice Blood Donors
预防新手献血者的不良反应
  • 批准号:
    7393301
  • 财政年份:
    2006
  • 资助金额:
    $ 35.61万
  • 项目类别:
Preventing Adverse Reactions in Novice Blood Donors
预防新手献血者的不良反应
  • 批准号:
    7464222
  • 财政年份:
    2006
  • 资助金额:
    $ 35.61万
  • 项目类别:

相似海外基金

A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis
治疗囊性纤维化患者 CFTR 调节剂治疗不良反应的个性化方法
  • 批准号:
    MR/X00094X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Research Grant
Identifying genetic polymorphisms and elucidating polygenic architecture associated with adverse reactions due to rituximab
识别遗传多态性并阐明与利妥昔单抗不良反应相关的多基因结构
  • 批准号:
    22K15910
  • 财政年份:
    2022
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanistic study of sulfa drug-induced severe cutaneous adverse reactions by focusing on HLA-A*11:01
以HLA-A*为重点的磺胺类药物致严重皮肤不良反应机制研究11:01
  • 批准号:
    22K06738
  • 财政年份:
    2022
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
  • 批准号:
    449379
  • 财政年份:
    2020
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Studentship Programs
Significance of gamma-chain in severe cutaneous adverse reactions
伽马链在严重皮肤不良反应中的意义
  • 批准号:
    19K17779
  • 财政年份:
    2019
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Historical sociology of adverse reactions related to vaccination in Japan
日本疫苗接种不良反应的历史社会学
  • 批准号:
    18K00267
  • 财政年份:
    2018
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SEARCH (active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare) & PREVENT (Pharmacogenomics of Adverse Reaction EVEnts National Team)
SEARCH(加拿大医疗保健不良反应的主动监测和评估)
  • 批准号:
    379425
  • 财政年份:
    2018
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Operating Grants
IGF::OT::IGF SBIR Phase II: Topic 338 - Predictive Biomarkers of Adverse Reactions to Prostrate Cancer Radiotherapy
IGF::OT::IGF SBIR II 期:主题 338 - 前列腺癌放射治疗不良反应的预测生物标志物
  • 批准号:
    9576448
  • 财政年份:
    2017
  • 资助金额:
    $ 35.61万
  • 项目类别:
Development of in silico prediction method for idiosyncratic adverse reactions associated with HLA genotypes
与 HLA 基因型相关的特殊不良反应的计算机预测方法的开发
  • 批准号:
    16K15156
  • 财政年份:
    2016
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Characterising the Immune Response to Drugs That Cause Idiosyncratic Adverse Reactions
表征对引起特殊不良反应的药物的免疫反应
  • 批准号:
    367156
  • 财政年份:
    2016
  • 资助金额:
    $ 35.61万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了